• Thurs news: GSK inks 2nd neuro pact in weeks. Teva episodic migraine trial. FDA clears AZ’s Imfinzi for aggressive lung cancer. Novartis fails to block generic Entresto. Nuvig gets immune drug funding. See more on our front page

RS Medical

Anonymous board for RS Medical
Replies
3
Views
3K
anonymous
Replies
5
Views
3K
anonymous
Replies
20
Views
9K
Anonymous
Replies
3
Views
3K
Anonymous
Replies
134
Views
26K
Anonymous
Replies
26
Views
10K
Anonymous
Replies
279
Views
103K
Anonymous
Replies
1
Views
3K
Anonymous
Replies
4
Views
5K
Anonymous
Replies
33
Views
13K
Anonymous
Replies
9
Views
7K
Anonymous
Replies
5
Views
8K
Anonymous